CONCIERGE MEDICINE BUSINESS PLAN
Â
I. Executive Summary
Company Description
The practice’s chosen name reflects a commitment to restoring time and trust in primary care and signals a membership-first approach to long-term health. We operate in the healthcare sector, specifically premium, membership-based primary care, and will launch in Austin, Texas in 2026. Our core offering is a flat-monthly-fee primary care membership that includes 24/7 direct access to personal physicians, same-day appointments, and comprehensive wellness planning. We combine advanced medical technology with a high-touch service model and maintain intentionally small patient panels so clinicians can deliver unhurried, deeply personalized care.
Day-to-day activities include member onboarding, longitudinal care planning, same-day clinical visits, remote and in-person consultations, and continuous patient monitoring through clinical technology. What sets us apart is the pairing of small panels with continuous physician availability and integrated wellness planning, not volume-driven visits. We target adults who value continuity, time with their physician, and proactive wellness management. Short-term goals are to open operations in Austin and reach stable panel capacity; long-term goals are to sustain low clinician-to-member ratios and replicate the model in comparable markets.
Â
Problem
The U.S. primary care system in 2026 remains reactive and overburdened: long waits, rushed 15-minute appointments, and fragmented access prevent physicians from building relationships or delivering preventive care. This produces delayed diagnoses, more avoidable crises, higher long-term costs, and poorer chronic disease control.
Patients need a different model that guarantees unhurried, personalized care—including 24/7 direct access, same-day appointments, and small patient panels—so clinicians can focus on prevention and continuity rather than volume. One-line: patients feel like numbers, not partners in their health.
Â
Solution
Membership-based primary care in Austin, Texas starting in 2026 replaces reactive, high-volume medicine with continuous, preventive care: 24/7 direct physician access, same-day or next-day extended visits, secure telehealth and messaging, intentionally small patient panels, and operations outside insurance visit constraints to support proactive wellness and chronic disease management.
One line: Small panels plus 24/7 direct access produce deeply personalized, prevention-first primary care.
Â
Mission Statement
Our mission is to transform the healthcare experience by restoring the physician–patient bond through personalized, proactive, and accessible care delivered in an unhurried, confidential environment where health and well‑being come first. We combine trustworthy, relationship-driven care with selective technology to empower members to meet long-term health goals through convenience, continuity, and deep understanding.
Â
Key Success Factors
Critical operational, financial, and commercial elements that determine early and long-term success.
-
Low patient-to-physician ratio to preserve the high-touch, concierge experience.
-
Breakeven in June 2026 as the early financial sustainability milestone.
-
Target CAC $150 through focused marketing to the Austin professional community.
-
$220,000‑salaried physicians hired and retained to ensure clinical excellence.
-
Recurring revenue with planned price escalations to support high long-term EBITDA margins.
Financial Summary
Brief financial snapshot for the Concierge Medicine executive summary.
Â
Ratio |
2026 |
2027 |
2028 |
Projected Revenue |
N/A |
N/A |
N/A |
Projected EBITDA |
$148,000 |
$932,000 |
$1,367,000 |
Expected ROI |
IRR 11.0% / ROE 6.72% |
IRR 11.0% / ROE 6.72% |
IRR 11.0% / ROE 6.72% |
Â
Financial requirements: Minimum cash required $696,000 with breakeven in June 2026 and a total payback period of 15 months; anticipated return metrics are IRR 11.0% and ROE 6.72%.
Overall outlook: disciplined costs and premium memberships drive strong EBITDA growth through 2030.
Â
Funding Requirements
$696,000 is required to fund launch through breakeven (Jun-26); projected EBITDA is $148,000 in 2026 and $2,273,000 by 2030, with a 15-month payback, IRR 0.11, and ROE 6.72.
Â
Categories |
Amount, USD |
Capital expenditures (total) |
$166,000 |
— EHR implementation (included above) |
$45,000 |
— Diagnostic equipment (included above) |
$35,000 |
— Clinic furniture (included above) |
$25,000 |
Marketing (initial) |
$36,000 |
Working capital |
$494,000 |
Total funding required |
$696,000 |
Â